|
| 36759418 | Proceedings of the First Pediatric Coma and Disorders of Consciousness Symposium by the Curing Coma Campaign, Pediatric Neurocritical Care Research Group, and NINDS: Gearing for Success in Coma Advancements for Children and Neonates. | Neurocrit Care | 2023 |
| 37104715 | The continuing challenges facing gene-targeted therapies. | Dev Med Child Neurol | 2023 |
| 36456201 | Academic Neurology and the COVID-19 Pandemic: Resilience, Hope, and Solutions. | Neurology | 2023 |
| 35180739 | An Article-Based Format for Medical Specialty and Subspecialty Maintenance of Certification. | J Contin Educ Health Prof | 2022 |
| 35404047 | Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors <i>In Vivo</i>. | J Med Chem | 2022 |
| 35487187 | The NINDS 2021-2026 Strategic Plan: Partnership and cross-cutting principles. | Cell | 2022 |
| 34561166 | Seeking progress in disease modification in Parkinson disease. | Parkinsonism Relat Disord | 2021 |
| 33589824 | Career equity in medicine. | Nat Med | 2021 |
| 34547463 | Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary. | Mol Ther | 2021 |
| 34399111 | Neurodevelopmental Clues to Neurodegeneration. | Pediatr Neurol | 2021 |
| 32415090 | PRMT1 promotes neuroblastoma cell survival through ATF5. | Oncogenesis | 2020 |
| 32896747 | Diversifying Child Neurology: Developing a Workforce That Reflects the Patients and Families for Whom We Care. | Pediatr Neurol | 2020 |
| 30938857 | Women in medical school leadership positions: Implications for research. | Ann Neurol | 2019 |
| 31690683 | Saving neurology: Once more with feeling. | Neurology | 2019 |
| 28834842 | The Decanal Divide: Women in Decanal Roles at U.S. Medical Schools. | Acad Med | 2018 |
| 29774131 | Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma. | Oncotarget | 2018 |
| 29290520 | A Life at the Interface: The 2017 Hower Award Lecture. | Pediatr Neurol | 2018 |
| 28800395 | Using Chemistry to Target Neuroblastoma. | ACS Chem Neurosci | 2017 |
| 28275082 | Autism today: Have we put the cart before the horse? | Neurology | 2017 |
| 28213359 | Methylation of the phosphatase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, and structural studies. | FASEB J | 2017 |
| 28615437 | Chance juxtapositions and (un)biased methods in science: More efficient at inefficiency. | Neurology | 2017 |
| 26843908 | Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells. | Oxid Med Cell Longev | 2016 |
| 28713571 | EYA1 expression and subcellular localization in neuroblastoma and its association with prognostic markers. | J Cancer Res Ther (Manch) | 2016 |
| 26640617 | Induction of Expression of p75 Neurotrophin Receptor Intracellular Domain Does Not Induce Expression or Enhance Activity of Mitochondrial Complex II. | Oxid Med Cell Longev | 2016 |
| 27566749 | Child neurologists and neurodevelopmental disabilities physicians: "Who-Who Are You?". | Neurology | 2016 |
| 27571165 | Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma. | Oncotarget | 2016 |
| 27372392 | The Electronic Medical Record and Computerized Physician Order Entry: Challenges and Opportunities for Pediatrics. | J Pediatr | 2016 |
| 27043043 | The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder. | Ann Neurol | 2016 |
| 26131461 | Author response. | Neurology | 2015 |
| 24253178 | p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma. | Cancer Chemother Pharmacol | 2014 |
| 25288697 | Comment: Autonomy vs beneficence. | Neurology | 2014 |
| 25346223 | Pursuit and achievement of leadership: a view from the top. | Ann Neurol | 2014 |
| 25072321 | Cerebellar Purkinje cell p75 neurotrophin receptor and autistic behavior. | Transl Psychiatry | 2014 |
| 23325901 | Pediatric neurohospitalists: an idea that has come of age? | Neurology | 2013 |
| 24303528 | Reflections: neurology and the humanities: personal health information in verse. | Neurology | 2013 |
| 23999075 | Kidins220/ARMS is expressed in neuroblastoma tumors and stabilizes neurotrophic signaling in a human neuroblastoma cell line. | Pediatr Res | 2013 |
| 23924772 | Introductory address for the John Howland Award recipient, Elizabeth R. McAnarney, MD. | Pediatr Res | 2013 |
| 23713087 | Why our patients (and we) need basic science research. | Neurology | 2013 |
| 23576410 | Aiming at neuroblastoma and hitting other worthy targets. | J Child Neurol | 2013 |
| 23575604 | Life at the interface: adults with "pediatric" disorders of the nervous system. | Ann Neurol | 2013 |
| 23314735 | p75NTR: an enhancer of fenretinide toxicity in neuroblastoma. | Cancer Chemother Pharmacol | 2013 |
| 23333500 | Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model. | Exp Cell Res | 2013 |
| 22821137 | Robert J. Joynt, MD, PhD: a tribute. | J Child Neurol | 2012 |
| 22786603 | Adult neurology training during child neurology residency. | Neurology | 2012 |
| 21150695 | Necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress. | Pediatr Res | 2011 |
| 22036500 | Pediatric residency preceding child neurology training. | Semin Pediatr Neurol | 2011 |
| 21869659 | Anticipatory guidance as a principle of faculty development: managing transition and change. | Acad Med | 2011 |
| 21904642 | Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress. | Oxid Med Cell Longev | 2011 |
| 21692548 | Pharmacologic management of high-risk neuroblastoma in children. | Paediatr Drugs | 2011 |
| 21387368 | What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us. | Ann Neurol | 2011 |